SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001052918-20-000179
Filing Date
2020-07-22
Accepted
2020-07-22 17:09:47
Documents
13
Period of Report
2019-08-31

Document Format Files

Seq Description Document Type Size
1 AVRICORE HEALTH INC. FORM 6K avricore6kaug2019.htm 6-K 10282
2 NEWS RELEASE ex99-1.htm EX-99 5871
3 MATERIAL CHANGE REPORT ex99-2.htm EX-99 3458
4 NEWS RELEASE ex99-3.htm EX-99 10935
5 MATERIAL CHANGE REPORT ex99-4.htm EX-99 12991
6 NEWS RELEASE ex99-5.htm EX-99 13419
7 INTERIM FINANCIAL STATEMENTS ex99-6.htm EX-99 287072
8 MANAGEMENT DISCUSSION AND ANALYSIS ex99-7.htm EX-99 111291
9 CERTIFICATION ex99-8.htm EX-99 6226
10 CERTIFICATION ex99-9.htm EX-99 6151
11 ex9931.jpg GRAPHIC 4440
12 ex9961.jpg GRAPHIC 6263
13 ex9971.jpg GRAPHIC 6263
  Complete submission text file 0001052918-20-000179.txt   492741
Mailing Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2
Business Address 789 WEST PENDER STREET SUITE 810 VANCOUVER A1 V6C 1H2 604-687-2038
Avricore Health Inc. (Filer) CIK: 0001355736 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-51848 | Film No.: 201042026
SIC: 2834 Pharmaceutical Preparations